QuadMedicine, Inc. (KOSDAQ:464490)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,900.00
+30.00 (0.62%)
At close: Sep 3, 2026

QuadMedicine Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
56,205176,813--
Market Cap Growth
----
Enterprise Value
46,946179,911--
Last Close Price
4895.0015590.00--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
PS Ratio
7.8716.53--
PB Ratio
2.295.74--
P/TBV Ratio
2.345.85--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
EV/Sales Ratio
6.5716.82--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
Debt / Equity Ratio
0.340.240.640.72
Net Debt / Equity Ratio
-0.38-0.65-0.250.22
Net Debt / EBITDA Ratio
1.466.492.24-0.26
Net Debt / FCF Ratio
0.952.971.31-0.20
Asset Turnover
0.180.260.33-
Quick Ratio
1.502.751.801.14
Current Ratio
1.582.871.851.29
Return on Equity (ROE)
-60.26%-32.69%-48.32%-
Return on Assets (ROA)
-15.67%-9.58%-9.70%-
Return on Capital Employed (ROCE)
-29.30%-15.80%-17.30%-44.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
Earnings Yield
-17.98%-3.92%--
FCF Yield
-17.30%-3.81%--
Buyback Yield / Dilution
-17.91%-10.16%-0.94%-